Advertisement

Cancer of the Testis

  • G. Pizzocaro

Abstract

Cancer of the testis is a relatively rare disease, but it was the commonest cause of cancer death in young adults until a few decades ago. Nowadays cancer of the testis is a potentially curable disease. This dramatic improvement started in the 1950s with a better knowledge of pathology and natural history, which led to an accurate use of surgery and radiotherapy. This improvement exploded in the 1970s with more sophisticated staging techniques and the introduction of cis-platinum combination chemotherapy.

Keywords

Clin Oncol Testicular Cancer Embryonal Carcinoma Germ Cell Cancer Retroperitoneal Lymphadenectomy 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Barzell WE, Whitmore WF (1979) Clinical significance of biologic markers. Semin Oncol 6: 48–52PubMedGoogle Scholar
  2. Birch R, Williams S, Cane A et al. (1986) Prognostic factors for favorable outcome in disseminated germ cell tumors. J Clin Oncol 4: 400–407PubMedGoogle Scholar
  3. Bosl GA, Geller NL, Cirrincione C et al. (1983) Multivariate analysis of prognostic variables in patients with metastatic testicular cancer. Cancer Res 43: 3404–3407Google Scholar
  4. Bosl GJ, Bajorin D, Leitner S et al. (1986) A randomized trial of etoposide plus cisplatin versus VAB-6 in good risk patients with germ cell tumor. Am Soc Clin Oncol 5: 104 (Abstract 405)Google Scholar
  5. Daugaard G, Rorth M (1985) High dose cisplatin and VP.16 in patients with poor risk prognosis germ cell cancer. Am Soc Clin Oncol 4: 99 (Abstract C-385)Google Scholar
  6. Einhorn LH, Donohue JP (1977) Cis -diammine dichloroplati-num, vinblastine and bleomycin combination chemotherapy in disseminated testicular cancer. Ann Intern Med 87: 293–298PubMedGoogle Scholar
  7. Einhorn LH, Williams SD (1980) Chemotherapy of disseminated testicular cancer: a random prospective study. Cancer 46: 1339–1344PubMedCrossRefGoogle Scholar
  8. Einhorn LH, Williams SD, Troner M et al. (1981) The role of maintenance therapy in disseminated testicular cancer. N Engl J Med 13: 727–731CrossRefGoogle Scholar
  9. Exelby PR (1980) Testicular cancer in children. Cancer 45: 1803–1809PubMedGoogle Scholar
  10. Loehrer PJ, Einhorn LH, Williams SD (1986) VP.16 plus ifosfa-mide plus cisplatin as salvage therapy in refractory germ cell cancer. J Clin Oncol 4: 528–536PubMedGoogle Scholar
  11. Mostofi PFK (1973) Testicular tumours: epidemiologic, etiologic and pathologic features. Cancer 32: 1186–1201PubMedCrossRefGoogle Scholar
  12. Mostofi FK (1980) Pathology of germ cell tumors of the testis. A progress report. Cancer 48: 1735–1754Google Scholar
  13. Ozols RF, Deisseroth AB, Javadpour N et al. (1983) Treatment of poor prognosis nonseminomatous testicular cancer with a high dose platinum combination chemotherapy regimen. Cancer 51: 1805–1807CrossRefGoogle Scholar
  14. Peckham MJ (1985) Surveillance following orchiectomy for clinical stage I testicular germ-cell malignancy. Acta Urol Belg 53: 155–164Google Scholar
  15. Peckham MJ, Hendry WF (1985) Clinical stage II nonseminomatous germ-cell testicular tumors. Results of management by primary chemotherapy. Br J Urol 57: 763–768PubMedCrossRefGoogle Scholar
  16. Peckham MJ, McElwain TJ, Barret A, Hendry WF (1979) Combined management of teratoma of the testis. Lancet 2: 267–269PubMedCrossRefGoogle Scholar
  17. Peckham MJ, Barret A, Liew KH et al. (1983) The treatment of metastatic germ-cell testicular tumors by bleomycin, etoposide and cisplatin (BEP). Br J Cancer 47: 613–619PubMedCrossRefGoogle Scholar
  18. Pizzocaro G (1985) Primary, secondary and salvage surgery in the management of germinal testis cancer. In: Jones WG, Milford Ward A, Anderson CK (eds) Germ cell tumours. Pergamon, Oxford, pp 395–402Google Scholar
  19. Pizzocaro G, Piva L, Salvioni R et al. (1984) Adjuvant chemotherapy in resected stage II nonseminomatous germ cell tumours of testis. Eur Urol 10: 151–158PubMedGoogle Scholar
  20. Pizzocaro G, Piva L, Salvioni R et al. (1985 a) Cisplatin, etoposide, bleomycin first-line therapy and early resection of residual tumor in far-advanced germinal testis cancer. Cancer 56: 2411–2415PubMedCrossRefGoogle Scholar
  21. Pizzocaro G, Salvioni R, Pasi M et al. (1985 b) Early resection of residual tumor during cisplatin, vinblastine, bleomycin combination chemotherapy in stage III and bulky stage II nonseminomatous testicular cancer. Cancer 56: 249–255PubMedCrossRefGoogle Scholar
  22. Pizzocaro G, Salvioni R, Zanoni F (1985 c) Unilateral lym-phadenectomy in intraoperative stage I nonseminomatous germinal testis cancer. J Urol 134: 485–489PubMedGoogle Scholar
  23. Pizzocaro G, Salvioni R, Piva L et al. (1986 a) Cisplatin combination chemotherapy in advanced seminoma. Cancer 58: 1625–1629PubMedCrossRefGoogle Scholar
  24. Pizzocaro G, Salvioni R, Zanoni F et al. (1986 b) Successful treatment of good-risk disseminated testicular cancer with cisplatin, bleomycin and reduced-dose vinblastine. Cancer 57: 2114–2128CrossRefGoogle Scholar
  25. Pizzocaro G, Zanoni F, Milani A et al. (1986 c) Orchiectomy alone in clinical stage I nonseminomatous testis cancer: a critical appraisal. J Clin Oncol 4: 35–40PubMedGoogle Scholar
  26. Pizzocaro G (1987) Retroperitoneal lymph node dissection in clinical stage IIA and IIB nonseminomatous germ-cell tumours of the testis. Int J Androl 10: 269–275PubMedCrossRefGoogle Scholar
  27. Reynolds TF, Vugrin D, Cvitkovic E et al. (1981) VAB-3 combination chemotherapy of metastatic testicular cancer. Cancer 48: 888–898PubMedCrossRefGoogle Scholar
  28. Richie JP, Garnick MB (1985) Limited retroperitoneal lymphadenectomy for patients with clinical stage I testicular tumours. J Urol 133–247 A (Abstract 534)Google Scholar
  29. Smalley SR, Evans RG, Richardson RC et al. (1985) Radiotherapy as initial treatment for bulky stage II testicular seminoma. J Clin Oncol 3: 1333–1338PubMedGoogle Scholar
  30. Stanton GF, Bosl GJ, Whitmore WF et al. (1985) VAB-6 as initial treatment of patients with advanced seminoma. J Clin Oncol 3: 336–339PubMedGoogle Scholar
  31. Swartz DA, Johnson DE, Hussey DH (1984) Should an elevated human chorionic gonadotropin titer alter therapy for seminoma? J Urol 131: 63–65PubMedGoogle Scholar
  32. Tamburini M, Filiberti A, Barbieri A et al. (1986) Psychosocial measurement of testicular cancer therapy. Preliminary data of a prospective study. International Workshop Quality of Life. 13 December 1985, MilanoGoogle Scholar
  33. Tesoro Tess JD, Pizzocaro G, Zanoni F, Musumeci R (1985) Lymphangiography and computed tomography in testicular carcinoma: how accurate is early stage disease? J Urol 133: 967–970PubMedGoogle Scholar
  34. Thomas GM (1985) Controversies in the management of testicular seminoma. Cancer 55: 2296–2302PubMedCrossRefGoogle Scholar
  35. Thomas GM, Rides WD, Dembo AJ et al. (1982) Seminoma of the testis: results of treatment and patterns of failure after radiation therapy. Int J Radiat Oncol Biol Phys 8:165–174PubMedCrossRefGoogle Scholar
  36. Vugrin D, Whitmore WF, Cvitkovic E et al. (1981a) Adjuvant chemotherapy combination of vinblastine, actinomycin D, bleomycin and clorambucil following retroperitoneal lymph node dissection in stage II testis tumour. Cancer 47: 840–844PubMedCrossRefGoogle Scholar
  37. Vugrin D, Whitmore WF, Cvitkovic E et al. (1981b) Adjuvant chemotherapy with VAB-3 of stage II-B testicular cancer. Cancer 48: 233–237PubMedCrossRefGoogle Scholar
  38. Vugrin D, Whitmore WF, Golbey RB (1983) VAB-6 combination chemotherapy without maintenance in the treatment of disseminated cancer of the testis. Cancer 51: 211–215PubMedCrossRefGoogle Scholar
  39. Williams SD, Einhorn LH, Greco FA et al. (1980) VP.16.213 salvage therapy for refractory germinal neoplasms. Cancer 46: 2154–2158PubMedCrossRefGoogle Scholar
  40. Williams SD, Einhorn LH, Greco FA et al. (1985) Disseminated germ cell tumors: a comparison of cisplatin plus bleomycin plus either vinblastine (PVB) or VP.16 (BEP). Am Soc Clin Oncol 4: 100 (Abstract C-390)Google Scholar
  41. Williams SD, Muggia F, Einhorn LH et al. (1986) Resected stage II testicular cancer: immediate adjuvant chemotherapy versus observation. Am Soc Clin Oncol 5: 98 (Abstract 380)Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1989

Authors and Affiliations

  • G. Pizzocaro

There are no affiliations available

Personalised recommendations